Compare ALB & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALB | STE |
|---|---|---|
| Founded | 1994 | 1985 |
| Country | United States | United States |
| Employees | N/A | 17787 |
| Industry | Major Chemicals | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.3B | 25.9B |
| IPO Year | 1994 | 1992 |
| Metric | ALB | STE |
|---|---|---|
| Price | $156.71 | $248.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 8 |
| Target Price | $155.05 | ★ $268.71 |
| AVG Volume (30 Days) | ★ 3.5M | 511.8K |
| Earning Date | 02-11-2026 | 02-04-2026 |
| Dividend Yield | ★ 0.96% | 0.95% |
| EPS Growth | N/A | ★ 52.13 |
| EPS | N/A | ★ 7.16 |
| Revenue | $4,946,415,000.00 | ★ $5,828,015,000.00 |
| Revenue This Year | N/A | $9.61 |
| Revenue Next Year | $8.75 | $6.23 |
| P/E Ratio | ★ N/A | $36.90 |
| Revenue Growth | N/A | ★ 7.96 |
| 52 Week Low | $49.43 | $204.90 |
| 52 Week High | $195.69 | $269.44 |
| Indicator | ALB | STE |
|---|---|---|
| Relative Strength Index (RSI) | 43.52 | 36.74 |
| Support Level | $164.15 | $260.91 |
| Resistance Level | $175.57 | $268.74 |
| Average True Range (ATR) | 8.91 | 6.20 |
| MACD | -4.07 | -0.97 |
| Stochastic Oscillator | 2.17 | 51.56 |
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.